¡GoConqr estrena diseño! Cuéntanos qué te parece.

Fichas

Hematology - Absite

Jennifer Huber Surgery - Absite Review Inglés 123 fichas

Fichas del conjunto (123)

  1. 1What are the 3 initial responses to vascular injury?vascular vasoconstriction
    platelet adhesion
    thrombin generation
  2. 2Intrinsic Pathwaycontact activation pathway
    most often initiated when factor XII (Hageman factor)
    Activates VIII, IX, XI
  3. 3Extrinsic Pathwaytissue factor pathway
    quicker responding and more direct
    releases Factor III + Ca
    Factor VII is activated
  4. 4Common PathwayIntrinsic and Extrinsic converge with
    Factor X.
    Fibrin is produced to seal off the vessel
  5. 5Prothrombin ComplexX, V, Ca, Platelet factor 3, prothrombin
    forms platelets
    catalyzes formation of thrombin
  6. 6What does fibrin do?links platelets together(binds GpIIb/IIIa molecules) to form platelet plug
    hemostasis
  7. 7What does Factor XIII do?helps cross-link fibrin
  8. 8Effects of ThrombinFibrinogen --> Fibrin + split products
    Activates factors V and VIII
    Activates platelets
  9. 9Effects of Antithrombin IIIBinds and inhibits Thrombin
    Inhibits factors IX, X & XI
  10. 10Effects of Heparin on Antithrombin IIIheparin activated antithrombin III up to 1000x normal activity
  11. 11Protein CVitamin K dependent
    degrades factors V and VIII
    degrades fibrinogen
  12. 12Protein Svitamin K dependent
    protein C co-factor
  13. 13Molecules associated with fibrinolysistissue plasminogen activator
    plasmin
    alpha-2 antiplasmin
  14. 14Tissue Plasminogen Activatorreleased from endothelium and converts plasminogen to plasmin
  15. 15Plasmindegrades factors V and VIII, fibrinogen and fibrin. Lose Platelet Plug
  16. 16Alpha-2 AntiplasminNatural Inhibitor of Plasmin
    released from endothelium
  17. 17Factor with the shortest half-lifeFactor VII
  18. 18What factors are lost in stored blood but not FFP?Factor V and VIII
  19. 19Which factor is not synthesized in the liver? Where is it synthesized?Factor VIII, it is synthesized in the endothelium along with vWF
  20. 20Which Factors are Vitamin K dependent?II, VII, IX, and X; protein C and S
  21. 21How long does it take for Vitamin K in IV form take to have an effect?12 hours
  22. 22What is Factor II?Prothrombin
  23. 23Normal half-life of RBC120days
  24. 24Normal half-life of platelets7 days
  25. 25Normal Half-life of PMNs1-2days
  26. 26Prostacyclin - where is it from? - what effects does it have?from endothelium
    decreases platelet aggregation
    promotes vasodilation
    antagonistic to TXA2
    increases cAMP in platelets
  27. 27Thromboxane (TXA2) - where is it from? - what are its effects?from platelets
    increases platelet aggregation
    promotes vasoconstriction
    triggers Ca release from platelets
    Exposes GpIIb/IIIa-R
  28. 28GpIIb/IIIa receptorwhen activated, causes platelet-to-platelet binding
  29. 29GpIb ReceptorWhen activated, platelet-to-collagen binding
  30. 30Cryoprecipitate - what does it contain? - What diseases is it commonly used for?contains the highest concentration of vWF-VIII and high levels of fibrinogen; used in vWD and Hemophilia A
  31. 31FFPFresh Frozen Plasma
    high levels of all coagulation factors
    protein C+S, AT-III
  32. 32DDAVP and conjugated estrogens release which factors?causes release of Factor VIII and vWF from endothelium
  33. 33What does prothrombin time (PT) measure?Factors II, V, VII, and X
    Fibrinogen
    best for liver synthetic function
  34. 34What does partial thromboplastin time measure? What range do we want?I, II, V, VIII, IX, X, XI and XII
    (not factors VII or XIII)
    Range: 60-90sec
  35. 35Activated Clotting Time we want for routine A/C vs for cardiopulmonary bypassroutine ACT: 150-200sec
    Cardiopulm Bypass ACT: >480sec
  36. 36relative contraindication to performing surgical procedures (INR)>1.5
  37. 37Relative contraindication for placing a central line, percut. needle biopsies, and eye surgeryINR >1.3
  38. 38MCC of surgical bleedingincomplete hemostasis
  39. 39MC congenital bleeding disordervon Willebrand's Disease
  40. 40MC symptom associated with vWDepistaxis
  41. 41Which type(s) of vWD are autosomal dominant?Type I and II
  42. 42Which type(s) of vWD are autosomal recessive?Type III
  43. 43Effects of vWFlinks GpIb receptor on platelets to collagen
  44. 44Effects of vWD on PT and PTTPT normal
    PTT normal or abn
  45. 45Effects of vWD on bleeding timeLong bleeding time
    Ristocetin Test
  46. 46MC type of vWDType I, mild symptoms
  47. 47Which type of vWD is most severe?Type III
  48. 48What is Type I vWD? and it's treatmentreduced quantity of vWF
    Tx: recombinant VIII:vWF, DDAVP, cryoprecipitate
    mostly DDAVP
  49. 49What is Type II vWD? what is its treatment?defect in vWF molecule, vWF doesn't work well
    Tx: recombinant VIII:vWF, cryoprecipitate and DDAVP
  50. 50what is Type III vWD? Treatment?complete vWF deficiency
    Tx: Recombinant VIII:vWF, cryoprecipitate
    NOT: DDAVP
  51. 51What is Hemophilia A? MC symptom?VIII deficiency
    Sex-linked recessive
    MC symptom: hemarthrosis
  52. 52PT and PTT in Hemophilia APT: normal
    PTT: prolonged, follow this 8hrs after surgery
  53. 53What to do for Hemophiliac joint bleedingice, keep joint mobile, factor VIII concentrate or cryoprecipitate
  54. 54Treatment for Hemophiliac epistaxis, ICH, or hematuriarecombinant factor IX or FFP
  55. 55Hemophilia B and treatmentIX Deficiency, Christmas Dx
    sex-linked recessive
    Tx: recombinant factor IX or FFP
  56. 56PT and PTT in Hemophilia BPT: normal
    PTT: prolonged
  57. 57Factor VII deficiency PT & PTT, and treatmentPT: prolonged
    PTT: normal
    bleeding tendency
    Tx: recombinant factor VII or FFP
  58. 58Symptoms associated with Platelet Disordersbruising, epistaxis, petechiae, purpura
  59. 59What can cause acquired thrombocytopeniaH2 blockers
    Heparin
  60. 60What is Glanzmann's Thrombocytopenia? Its treatmentGpIIb/IIIa-R deficiency on plts
    platelets can't bind together
    Tx: platelets
  61. 61Bernard Soulier and its treatmentGpIb-R Deficiency on platelets
    cannot bind to collagen
    Tx: platelets
  62. 62Uremia and its effect on platelets TreatmentBUN >60-80
    inhibits plt fxn, mainly but inhibiting release of vWF
    Tx: HD, for acute reversal use DDVAPm cryoprecipitate for moderate to severe bleeding
  63. 63Antibody associated with HIT syndromeanti-heparin antibodies or IgG heparin-PF4 antibody
  64. 64Difference between HIT and HITTHIT: heparin induce thrombocytopenia
    HITT: thrombosis
  65. 65Clinical Signs of HITPlatelets <100 or drop in platelets >50% admission levels
    or thrombosis while on heparin
  66. 66Type a clot that is formed associated with HIT syndromewhite clot
  67. 67Diagnostic Testing for HIT syndromeELISA for heparin Abs
    Serotonin Release Assay
  68. 68Treatment of HIT syndromestop heparin
    start agatroban (direct thrombin inhibitor)
    avoid giving plts
  69. 69What is DIC? What is increased and decreased on bloodwork?Disseminated Intravascular Coagulation
    decreased plts, fibrinogen
    high D-Dimer fibrin split prod
    Prolonged PT and PTT
  70. 70Treatment for DICtreat the underlying cause
  71. 71When do you stop aspirin before surgery?7days before surgery
  72. 72MoA and Effects of aspirininhibits cyclooxygenase in plts and decreases TXA2
    Causes prolonged bleeding time
  73. 73When to Stop Clopidogrel (Plavix) before surgery7 days prior to surgery
  74. 74MoA of clopidogrelADP receptor antagonist
  75. 75How to treat someone for bleeding while on Clopidogrel/PlavixPlatelets
  76. 76What to do for a patient with coronary stent and need to stop Plavix for elective surgery?bridge with Integrilin (eptifibatide)
    GpIIb/IIIa inhibitor
  77. 77Treatment for bleeding in a patient on CoumadinVit K and FFP
  78. 78When to stop Coumadin prior to surgery7days prior
  79. 79Platelet levels prior to surgery and after surgeryprior >50,000
    after >20,000
  80. 80Effects of prostate surgery on coagulationIt can release urokinase, activate plasminogen and cause thrombolysis
  81. 81Best way to predict bleeding riskH&P
  82. 82MC congenital hypercoagulability disorderFactor Leiden V Mutation
  83. 83Effects of Factor Leiden V mutationcauses venous thromboses
    resistance to activated protein C
    defect on Factor V
  84. 84Tx for Factor Leiden V mutationheparin, warfarin
  85. 85Effects of hyperhomocysteinemia and treatment for ithypercoagulability
    Tx: folic acid and B12
  86. 86Prothrombin gene defect G20210Agene mutation in which a guanine (G) is changed to a adenine (A) at position 20210
    in prothrombin gene
    causes DVT and PE
  87. 87Treatment of G20210AHeparin, Warfarin
  88. 88Treatment of Protein C or S deficiencyHeparin, Warfarin
  89. 89Polycythemia VeraBM overproduction
    can get thrombosis
  90. 90What platelet and Hct levels are expected in patients with Polycythemia Vera prior to surgery?Hct <48
    Platelets <400
  91. 91Treatments for Polycythemia VeraPhlebotomy
    ASA
    Hydroxyurea
  92. 92Symptoms with Anti-phospholipid antibody syndromethromboses and loss of pregnancy
  93. 93Antibodies associated with anti-phospholipid antibody syndromecardiolipin (mitochrondria)
    lupus anticoagulant (cell membrane)
  94. 94Diagnostic Tests for Anti-phospholipid Ab Syndrome (not antibodies)prolonged PTT, not corrected with FFP
    (+) Russell viper venom time
    false positive RPR
  95. 95Treatment for anti-phospholipid antibody syndromeheparin, warfarin
  96. 96MC factor for acquired hypercoagulabilityTOBACCO
  97. 97Name 10 Causes of Acquired Hypercoaguable statesTobacco, Malignancy, Inflammatory States, IBD, Infections, OCP, Pregnancy, RA,
    Post-op patients, myeloproliferative disorders
  98. 98Warfarin-induced skin necrosiswhen someone is on Coumadin without being heparinized first, d/t short t1/2 of proteins C&S.
    Esp. in protein C deficiency patients
  99. 99Tx of Warfarin-induced skin necrosisheparin, otherwise best to just prevent with heparin before starting
  100. 100Virchow's Triadelements for venous thromboses
    stasis, endothelial injury, hypercoagulability
  101. 101Key element in the development of arterial thrombosisEndothelial injury
  102. 102Indications for IVC filter placementcontraindications for A/C
    PE while on A/C
    free-floating IVC, ilio-femoral or deep femoral DVT
    recent pulmonary embolectomy
  103. 103How to treat someone for DVT post-op 1st time? 2nd time? 3rd time?1st: Warfarin x 6mon
    2nd: warfarin x 1 year
    3rd/significant PE: warfarin lifetime
  104. 104MC origin for PEilio-femoral region
  105. 105Aminocaproic Acid (amicar) MoAinhibits fibrinolysis by inhibiting plasmin
  106. 106When to use Aminocaproic AcidDIC, persistent bleeding following cardiopulmonary bypass,
    thrombolytic overdoses
  107. 107MoA of Warfarinprevents vitamin-K dependent decarboxylation of glutamic residues on vitamin K dependent factors
  108. 108List 3 direct thrombin inhibitors (PO)Dabigatran (Pradaxa)
    Apixiban (Eliquis)
    Rivaroxaban (Xarelto)
  109. 109How do sequential compression devices (SCDs) work?improve venous return and induce fibrinolysis with compression (releases tPA from endothelium)
  110. 110How to reverse heparinProtamine
  111. 111Half-life of heparin60-90minutes
  112. 112How is heparin cleared from the system?Reticuloendothelial System (spleen, macrophages)
  113. 113Protamine ReactionCan occur in patients who are on NPH insulin or previous protamine exposure.
    HoTN, Bradycardia, decreased heart fx
  114. 114which anticoagulant is safer to use in pregnancy? and why? Heparin or WarfarinHeparin, it does not cross the placental barrier
  115. 115Low Molecular Weight HeparinEnoxaparin
    lower risk of HIT compared to unfractionated
    binds and activated antithrombin-III
    increases neutralization of Factor Xa
  116. 116Argatrobanreversible direct thrombin inhibitor
    metabolized by proteinase enzymes in blood
    half-life is 50minutes
  117. 117Bivalirudin (Angiomax)reversible direct thrombin inhibitor, metabolized by proteinase enzymes in blood
    half-life is 25minutes
  118. 118Hirudin (Hirulog)From Leeches
    irreversible direct thrombin inhibitor
    Most potent direct inhibitor of thrombin
  119. 119AncrodMalayan pit viper venom
    stimulates tPA release
  120. 1203 thrombolyticstPA
    Streptokinase
    Urokinase
  121. 121Absolute Contraindications for Thrombolyticsactive internal bleeding; recent CVA or Neurosurgery (<3mo); intracranial pathology, recent GI bleed
  122. 122Major Contraindications to Thrombolytic UseRecent (<10d) surgery, organ biopsy, or obstetric delivery, left heart thrombosis, active peptic ulcer, recent major trauma, uncontrolled HTN, recent eye surgery
  123. 123Minor Contraindications to Thrombolyticsminor surgery, recent CPR, AFib with mitral valve disease, bacterial endocarditis, hemostatic defects, diabetic hemorrhagic retinopathy, pregnancy

Información

Descripción
Surgery - Absite Review Fichas sobre Hematology - Absite, creado por Jennifer Huber el 29/05/2018.
Creado por
Jennifer Huber
Visitas
23
Valoración

Escríbenos

¿Sobre qué es tu mensaje?

¿Qué te parece el nuevo diseño?

¿Te gusta?